<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03942835</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL18_0376</org_study_id>
    <secondary_id>2018-A02597-48</secondary_id>
    <nct_id>NCT03942835</nct_id>
  </id_info>
  <brief_title>Psychometric Validation of the Competitive Attention Test</brief_title>
  <acronym>CAT</acronym>
  <official_title>Psychometric Validation of the Competitive Attention Test (CAT) : Simultaneous and Separated Measures of Voluntary and Involuntary Attention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims at validating a new neuropsychological test to measure voluntary and
      involuntary attention for clinical use to diagnose attentional deficits.

      This project proposes:

        -  a test-retest procedure in healthy subjects aged from 6 to 90 year-old;

        -  testing in attention deficit hyperactivity disorder (ADHD) patients before
           psychostimulant treatment;

        -  testing in attention deficit hyperactivity disorder (ADHD) patients before
           psychostimulant treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 21, 2020</start_date>
  <completion_date type="Anticipated">January 21, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 21, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reaction times in healthy subjects and patients with ADHD.</measure>
    <time_frame>6 weeks</time_frame>
    <description>Reaction times in milliseconds obtained with the CAT test in healthy participants and in patients with ADHD.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of correct responses in healthy subjects and patients with ADHD.</measure>
    <time_frame>6 weeks</time_frame>
    <description>Percentage of correct responses obtained with the CAT test in healthy participants and in patients with ADHD.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder</condition>
  <arm_group>
    <arm_group_label>Healthy participants aged from 6 to 90 year-old</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with ADHD with no treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with ADHD aged from 6 to 90 year-old with no treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with ADHD with treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with ADHD aged from 6 to 90 year-old with psychostimulant treatment (Methylphenidate)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>experience 1 : Competitive attention test in healthy participants</intervention_name>
    <description>Comparison of behavioral measures (reaction times and percentage of correct responses) obtained twice with the CAT test in healthy participants (2 to 6 weeks apart).</description>
    <arm_group_label>Healthy participants aged from 6 to 90 year-old</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>experience 2 : Competitive attention test in patients with ADHD with no treatment</intervention_name>
    <description>Behavioral (reaction times and percentage of correct responses) and Electroencephalography (EEG) measures obtained with the CAT test in patients with ADHD with no treatment.</description>
    <arm_group_label>patients with ADHD with no treatment</arm_group_label>
    <arm_group_label>patients with ADHD with treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>experience 3 :Competitive attention test in patients with ADHD with psychostimulant treatment</intervention_name>
    <description>Behavioral (reaction times and percentage of correct responses) and EEG measures obtained with the CAT test in patients with ADHD before and after psychostimulant treatment.</description>
    <arm_group_label>patients with ADHD with treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        healthy major participants:

          -  Age from 18 to 90 year-old

          -  Informed consent to participate in the study

          -  No neurological or psychiatric disorder

          -  No history of neuro-psychiatric disorder or neurodevelopmental type dysphasia,
             dyslexia, dyspraxia, attention deficit disorder

        healthy minor participants:

          -  Age from 6 to 17 year-old

          -  Informed consent of parents or guardians for the child's participation in the study

          -  No neurological or psychiatric disorder

          -  No history of neuro-psychiatric disorder or neurodevelopmental type dysphasia,
             dyslexia, dyspraxia, Attention deficit disorder

        ADHD minor patients:

          -  Age from 6 to 17 year-old

          -  Informed consent of parents or guardians for the child's participation in the study

          -  ADHD Diagnosis with or without hyperactivity

          -  No psychiatric history other than ADHD.

          -  For Experience 3: treatment in progress.

        Exclusion Criteria:

        healthy major participants

          -  Age below 18 or above 90 year-old

          -  unaffiliated or non-beneficiaries of the social security scheme

        healthy minor participants:

          -  Age below 6 or above 18 year-old

          -  unaffiliated or non-beneficiaries of the social security scheme

        ADHD minor patients:

          -  Age below 6 or above 18 year-old

          -  unaffiliated or non-beneficiaries of the social security scheme
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aurélie BIDET-CAULET, PhD, CR</last_name>
    <phone>04 72 13 89 31</phone>
    <phone_ext>+33</phone_ext>
    <email>aurelie.bidet-caulet@inserm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lesly FORNONI, TR</last_name>
    <phone>04 72 13 89 22</phone>
    <phone_ext>+33</phone_ext>
    <email>lesly.fornoni@inserm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre de Recherche en Neurosciences de Lyon, INSERM U1028</name>
      <address>
        <city>Bron</city>
        <zip>69675</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurélie BIDET-CAULET, PhD, CR</last_name>
      <phone>04 72 13 89 31</phone>
      <phone_ext>+33</phone_ext>
      <email>aurelie.bidet-caulet@inserm.fr</email>
    </contact>
    <contact_backup>
      <last_name>Lesly FORNONI, TR</last_name>
      <phone>04 72 13 89 22</phone>
      <phone_ext>+33</phone_ext>
      <email>lesly.fornoni@inserm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Aurélie BIDET-CAULET, PhD, CR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>April 30, 2019</study_first_submitted>
  <study_first_submitted_qc>May 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2019</study_first_posted>
  <last_update_submitted>January 23, 2020</last_update_submitted>
  <last_update_submitted_qc>January 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Attention Deficit Hyperactivity Disorder</keyword>
  <keyword>attention</keyword>
  <keyword>distraction</keyword>
  <keyword>psychometric test</keyword>
  <keyword>neuropsychological test validating procedure</keyword>
  <keyword>psychostimulant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

